Profile
Dr. Ting Jia is a Chief Investment Officer at Octagon Capital Advisors LP and a Founder at Octagon Capital Advisor/ Private Equity.
He is on the Board of Directors at AnHeart Therapeutics LLC, Bluejay Therapeutics, Inc. and Vedere Bio II, Inc.
Dr. Jia was previously employed as a Managing Director by Hillhouse Capital Management Pte Ltd. and an Investment Analyst by BVF Partners LP.
He received his undergraduate degree from Sun Yat-Sen University and a doctorate degree from Weill Cornell Graduate School of Medical Sciences.
TJ Jia active positions
| Companies | Position | Start |
|---|---|---|
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Director/Board Member | - |
AnHeart Therapeutics, Inc.
AnHeart Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapies | Director/Board Member | - |
Bluejay Therapeutics, Inc.
Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Director/Board Member | - |
Octagon Capital Advisor/ Private Equity
Octagon Capital Advisor/ Private Equity Investment ManagersFinance Octagon Capital invests invests in both public and private companies across the globe. The firm targets companies operating in the fields of technology sectors and industries. It provides financing for early and buyout stage capital requirements. | Founder | 01/01/2019 |
Octagon Capital Advisors LP
Octagon Capital Advisors LP Investment ManagersFinance Octagon seeks to provide attractive risk-adjusted returns by investing in healthcare companies with long-term compounding growth potentials on behalf of clients. Clients typically invest in securities and financial instruments of companies in the healthcare sector globally, with focuses in companies headquartered in the US, China, the European Union, and the UK. They employ a bottom-up, fundamental company analysis when selecting client investments. | Chief Executive Officer | 30/10/2019 |
Former positions of TJ Jia
| Companies | Position | End |
|---|---|---|
HHLR Management Pte Ltd.
HHLR Management Pte Ltd. Investment ManagersFinance HHLR is a long-term investor that invests in high-quality businesses across Asia and the world. | Private Equity Investor | 31/12/2019 |
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Corporate Officer/Principal | 01/01/2015 |
Training of TJ Jia
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Finance |
Sun Yat-Sen University
Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Graduate School of Medical Sciences
Weill Cornell Graduate School of Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HHLR Management Pte Ltd.
HHLR Management Pte Ltd. Investment ManagersFinance HHLR is a long-term investor that invests in high-quality businesses across Asia and the world. | Finance |
Octagon Capital Advisors LP
Octagon Capital Advisors LP Investment ManagersFinance Octagon seeks to provide attractive risk-adjusted returns by investing in healthcare companies with long-term compounding growth potentials on behalf of clients. Clients typically invest in securities and financial instruments of companies in the healthcare sector globally, with focuses in companies headquartered in the US, China, the European Union, and the UK. They employ a bottom-up, fundamental company analysis when selecting client investments. | Finance |
AnHeart Therapeutics, Inc.
AnHeart Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapies | Health Technology |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Commercial Services |
Bluejay Therapeutics, Inc.
Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Health Technology |
Octagon Capital Advisor/ Private Equity
Octagon Capital Advisor/ Private Equity Investment ManagersFinance Octagon Capital invests invests in both public and private companies across the globe. The firm targets companies operating in the fields of technology sectors and industries. It provides financing for early and buyout stage capital requirements. | Finance |
- Stock Market
- Insiders
- TJ Jia
















